CTP (Cytidine Triphosphate) activators are a subset of biochemical compounds that primarily focus on the upregulation of the synthesis or availability of CTP, a key nucleotide involved in cellular metabolism. These compounds can work through a variety of mechanisms, including but not limited to the direct activation of enzymes responsible for CTP biosynthesis, such as CTP synthetase. Additionally, they may also operate by inhibiting competing pathways or enzymes that consume or degrade CTP, thereby leading to an overall increase in cellular CTP levels. Notably, CTP activators can be either naturally occurring molecules like certain coenzymes and metabolites or synthetic compounds designed to target specific biochemical pathways. Moreover, the upregulation of CTP can have a ripple effect on other nucleotide pools and metabolic pathways, affecting cellular functions like DNA replication, RNA transcription, and lipid biosynthesis.
The mechanisms by which CTP activators function can be highly nuanced and context-dependent. Some CTP activators may directly bind to the active site or an allosteric site of enzymes involved in CTP biosynthesis, thereby increasing their activity. Others may work indirectly by affecting the levels of substrates and cofactors required for CTP synthesis. For instance, some compounds might increase the levels of cytidine or uridine, which are precursors for CTP. Yet others may affect the energy balance within the cell by modulating levels of ATP or GTP, which are often required for the conversion of precursors to CTP. Due to these diverse mechanisms, the biochemistry of CTP activators is a subject of ongoing research to understand their role in cellular metabolism better.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Inhibits thymidylate synthase, leading to imbalances in nucleotide pools and subsequently increased CTP levels. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, affecting nucleotide synthesis and increasing CTP expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, affecting dNTP pools and inducing CTP expression. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Inhibits ribonucleotide reductase and DNA polymerase, causing nucleotide pool imbalances and CTP induction. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
Inhibits dihydrofolate reductase, affecting nucleotide synthesis and increasing CTP expression. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $150.00 $263.00 $518.00 $731.00 $1461.00 | 1 | |
Inhibits DNA polymerase, leading to nucleotide imbalances and subsequently increased CTP levels. | ||||||
6-Mercaptopurine | 50-44-2 | sc-361087 sc-361087A | 50 mg 100 mg | $72.00 $104.00 | ||
Inhibits purine synthesis, affecting nucleotide pools and inducing CTP expression. | ||||||